SAN DIEGO–(BUSINESS WIRE)–Feb. 13, 2024– Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report fourth quarter and full year 2023 financial results on Tuesday, February 27, 2024, after the close of the U.S. financial markets. Acadia’s management team will also host a conference call and webcast on February 27, 2024, at 4:30 p.m. Eastern Time to discuss financial results and operations.
- Forums
- ASX - By Stock
- Acadia
SAN DIEGO–(BUSINESS WIRE)–Feb. 13, 2024– Acadia Pharmaceuticals...
- There are more pages in this discussion • 376 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$20.73 |
Change
-0.280(1.33%) |
Mkt cap ! $2.647B |
Open | High | Low | Value | Volume |
$20.87 | $21.19 | $20.70 | $6.213M | 297.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 5414 | $20.72 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.79 | 335 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1072 | 20.720 |
1 | 1089 | 20.670 |
3 | 3987 | 20.660 |
1 | 50 | 20.650 |
2 | 2292 | 20.630 |
Price($) | Vol. | No. |
---|---|---|
20.850 | 1080 | 2 |
20.860 | 1089 | 1 |
20.890 | 1089 | 2 |
20.930 | 1089 | 1 |
20.960 | 1089 | 1 |
Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
Last
$20.73 |
  |
Change
-0.280 ( 1.22 %) |
|||
Open | High | Low | Volume | ||
$20.99 | $21.19 | $20.69 | 94423 | ||
Last updated 15.59pm 21/05/2024 ? |
Featured News
NEU (ASX) Chart |
The Watchlist
AUQ
ALARA RESOURCES LIMITED
Stephen Gethin, Non-Executive Director & Chairman
Stephen Gethin
Non-Executive Director & Chairman
Previous Video
Next Video
SPONSORED BY The Market Online